Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PHENAPHEN W/ CODEINE NO. 2

ACETAMINOPHEN; CODEINE PHOSPHATE

Standard Dose
325MG;15MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PHENAPHEN W/ CODEINE NO. 2 is listed in Drugs@FDA under application 084444 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength CAPSULE;ORAL - 325MG;15MG Sponsor ROBINS AH Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview PHENAPHEN W/ CODEINE NO. 2 is listed in Drugs@FDA under application 084444 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength CAPSULE;ORAL - 325MG;15MG Sponsor ROBINS AH Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.